Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study.

Tevimbra (tislelizumab-jsgr) - BeOne Medicines

AiRuiKa (camrelizumab) - Elevar Therapeutics

Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42421691

Chunyu Tian; Juyi Wu; Qiong Li; Shaojie Yang; Shujuan Zhou; Xiaola Xue; Xuan Yang; Yuchao Xia; Zhenpeng Tan

Jul 10, 2026